Opus Genetics, Inc. · NASDAQ:IRD
Caligan Partners LP reported a 7.30% stake in Opus Genetics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Caligan Partners LP reported a 7.30% stake in Opus Genetics, Inc., 6,077,084 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 7.30%
- Shares
- 6,077,084
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Caligan Partners LP | 7.30% | 6,077,084 |
| JOHNSON DAVID EDWARD | 7.30% | 6,077,084 |
Source
Related
- Opus Genetics, Inc.
- Caligan Partners LP
- Opus Genetics, Inc. shareholders
- Schedule 13G · Caligan Partners LP · May 15, 2026
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026